Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Julie Errington.

Newcastle AuthorsTitleYearFull text
Dr Catherine Gowland
Philip Berry
Julie Errington
Professor Gareth Veal
Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study2021
Dr Shelby Barnett
Julie Errington
Julieann Sludden
Dr David Jamieson
Professor Gareth Veal
et al.
Pharmacokinetics and pharmacogenetics of cyclophosphamide in a neonate and infant childhood cancer patient population2021
Professor Gareth Veal
Professor Deborah Tweddle
Julie Errington
Pharmacokinetics and safety of a novel oral liquid formulation of 13-cis retinoic acid in children with neuroblastoma: A randomized crossover clinical trial2021
Dr Rosanna Jackson
Philip Berry
Julie Errington
Professor Julie Irving
Professor Gareth Veal
et al.
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia - a report from the UKALL 2011 trial2019
Professor Gareth Veal
Julie Errington
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: A re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function2019
Professor Gareth Veal
Julie Errington
Dr Leigh McDonald
Professor Deborah Tweddle
The use of pharmacokinetically guided carboplatin chemotherapy in a pre-term infant with neuroblastoma-associated spinal cord compression2019
Professor Gareth Veal
Julie Errington
Adaptive dosing of anticancer drugs in neonates – facilitating evidence-based dosing regimens2016
Professor Gareth Veal
Julieann Sludden
Dr David Jamieson
Julie Errington
Dr Ghada Malik
et al.
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin’s lymphoma2016
Julie Errington
Dr Ghada Malik
Lisa Price
Professor Gareth Veal
Investigating the Experiences of Childhood Cancer Patients and Parents Participating in Optional Nontherapeutic Clinical Research Studies in the UK2016
Professor Gareth Veal
Julie Errington
Dr James Hayden
Professor Deborah Tweddle
Carboplatin therapeutic monitoring in preterm and full-term neonates2015
Professor Gareth Veal
Julie Errington
Dr James Hayden
Professor Deborah Tweddle
Carboplatin therapeutic monitoring in preterm and full-term neonates2015
Professor Gareth Veal
Julie Errington
Professor Deborah Tweddle
Therapeutic drug monitoring approaches to the treatment of preterm and full-term neonates with cancer - A UK experience2015
Dr Chris Hill
Julie Errington
Dr Ghada Malik
Professor Alan Boddy
Professor Gareth Veal
et al.
Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer2014
Professor Gareth Veal
Julie Errington
Sophie Rowbotham
Nicola Illingworth
Dr Ghada Malik
et al.
Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma2013
Professor Gareth Veal
Julie Errington
Dr Ghada Malik
Dr Chris Hill
Professor Alan Boddy
et al.
Investigating the pharmacokinetics and dosing of anticancer drugs in infants and young children2013
Julie Errington
Professor Alan Boddy
Professor Gareth Veal
Mike Cole
Pharmacokinetics of cyclophosphamide and its metabolites in pediatric patients receiving high-dose myeloablative therapy2011
Julie Errington
Professor Alan Boddy
Professor Gareth Veal
Mike Cole
Pharmacokinetics of high-dose cyclophosphamide and its metabolites in paediatric patients2011
Professor Gareth Veal
Julie Errington
Professor Andrew Pearson
Professor Alan Boddy
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients2010
Julie Errington
Professor Alan Boddy
Professor Gareth Veal
Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma2009
Professor Gareth Veal
Julie Errington
Dr Michael Tilby
Professor Alan Boddy
Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours2007
Professor Alan Boddy
Melanie Griffin
Julie Errington
Professor Gareth Veal
Dosing of cancer patients with low or absent renal function2007
Professor Gareth Veal
Mike Cole
Geoffrey Taylor
Julie Errington
Professor Alan Boddy
et al.
Pharmacogenetics and metabolism of cyclophosphamide in paediatric cancer patients2007
Professor Gareth Veal
Mike Cole
Julie Errington
Professor Alan Boddy
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - A study of the United Kingdom Children's Cancer Study Group2007
Professor Gareth Veal
Julie Errington
Huw Thomas
Professor Alan Boddy
Biliary excretion of etoposide in children with cancer2006
Professor Gareth Veal
Mike Cole
Julie Errington
Annie Parry
Dr Juliet Hale
et al.
Pharmacokinetics of dactinomycin in a pediatric patient population: A United Kingdom Children's Cancer Study Group study2005
Professor Gareth Veal
Julie Errington
Julieann Sludden
Melanie Griffin
Annie Parry
et al.
Determination of anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry2003
Julie Errington
Professor Gareth Veal
Julieann Sludden
Melanie Griffin
Professor Andrew Pearson
et al.
Determination of the anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry2003
Professor Gareth Veal
Julie Errington
Professor Andrew Pearson
Professor Alan Boddy
Poster Presentation: Oxidative metabolism of 13-cis-retinoic acid in children with neuroblastoma2003
Professor Gareth Veal
Julie Errington
Dr Chris Redfern
Professor Andrew Pearson
Professor Alan Boddy
et al.
Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells2002
Dr Xiaomei Lu
Julie Errington
Professor Nicola Curtin
Professor John Lunec
Professor Herbie Newell
et al.

The impact of p53 status on cellular sensitivity to antifolate drugs

2001
Professor Gareth Veal
Dr Cinera Dias
Annie Parry
Julie Errington
Dr Juliet Hale
et al.
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy2001
Professor Gareth Veal
Julie Errington
Dr Chris Redfern
Professor Andrew Pearson
Professor Alan Boddy
et al.
Influence of retinoid isomerisation on the cellular activity of 13-cis retinoic acid in neuroblastoma2001
Dr Xiaohong Lu
Julie Errington
Professor Nicola Curtin
Professor Alan Boddy
Professor Herbie Newell
et al.
Cellular ATP depletion by LY309887 as a predictor of growth inhibition in human tumor cell lines2000